U.S. Healthcare Services Stock News

CBL Properties recently refinanced its existing US$634 million term loan through two transactions: a US$425 million non-recourse financing secured by primarily mall properties and an anticipated US$176 million floating-rate loan backed by open-air lifestyle centers. This refinancing not only extends debt maturities and reduces overall borrowings but is also expected to lift estimated annual free cash flow by more than US$30 million, highlighting renewed lender confidence in market-dominant...

Niu Technologies (NasdaqGM:NIU) closed out FY 2025 with fourth quarter revenue of C¥676.2 million and a basic EPS loss of C¥1.10, alongside trailing twelve month revenue of C¥4.3 billion and a basic EPS loss of C¥0.49. Over recent quarters the company has seen revenue range from C¥681.9 million to C¥1.7 billion, with quarterly basic EPS swinging between a loss of C¥0.49 and a profit of C¥1.02. This underscores how volatile earnings have been around a still unprofitable margin profile. See our...

Investors may be wondering whether Johnson Controls International is priced attractively right now or if the recent run means most of the value is already reflected in the US$131.69 share price. The stock has pulled back by 1.1% over the last week and 5.4% over the last month, yet it still shows returns of 7.7% year to date, 64.5% over 1 year, 138.4% over 3 years and 143.1% over 5 years. Recent coverage has focused on Johnson Controls International as an established player in capital goods...

Why Axalta Coating Systems (AXTA) Is Back Under Pressure Axalta Coating Systems (AXTA) has come under fresh scrutiny after underperforming in its latest quarter and guiding to a mid single digit revenue decline, alongside rising raw material costs and softer North American demand. See our latest analysis for Axalta Coating Systems. The Q4 2025 earnings miss and softer Q1 2026 outlook have been reflected in the share price, with a 30 day share price return showing an 18.17% decline and a 1...

Safety Insurance Group (SAFT) is in focus after reporting an improved combined ratio of 99% in 2024, a well covered dividend, and a 4.2% yield on its investment portfolio. See our latest analysis for Safety Insurance Group. The share price sits at $73.53 after a 1 day share price return of 0.40% and a 7 day share price return of 1.21%. However, the 30 day share price return of 7.31% and year to date share price return of 2.88% point to fading short term momentum. The 3 year total shareholder...

In March 2026, GRAIL, Inc. announced that CEO Bob Ragusa will retire on June 1, 2026, with President Josh Ofman, MD, MSHS, set to become CEO and join the Board, while Ragusa remains as a senior advisor through March 2027. This leadership transition places a long-time internal executive with deep clinical and health policy experience at the center of GRAIL’s next phase of development. Next, we’ll examine how Ofman’s planned move from president to CEO could reshape GRAIL’s investment narrative...

Townsquare Media (TSQ) FY 2025 Earnings Snapshot Townsquare Media (TSQ) has wrapped up FY 2025 with Q4 revenue of US$106.5 million and a basic EPS loss of US$0.32, while trailing twelve month figures show revenue at US$427.4 million and a basic EPS loss of US$0.71. Over recent quarters the company has seen revenue move from US$117.8 million in Q4 2024 to US$106.5 million in Q4 2025, with EPS shifting from a profit of US$1.59 to a loss of US$0.32. This sets up a story where revenue is...

Why Envista Holdings is on investors’ radar today Envista Holdings (NVST) is back in focus after recent trading, with the share price closing at $25.02 and short term returns mixed between a 1 day gain and a weaker past week. Over the past month the stock has recorded a 14% decline, while the past 3 months show a 14% total return, giving investors a compact snapshot of recent volatility and recovery. See our latest analysis for Envista Holdings. That recent 14.25% 3 month share price return...

In March 2026, Vistra Corp reported fourth-quarter 2025 earnings that missed market expectations on both earnings per share and revenue, while Executive Vice President and General Counsel Stephanie Zapata Moore sold 10,000 shares under a pre-arranged Rule 10b5-1 trading plan. The combination of an earnings miss alongside ongoing insider selling activity, including Moore’s cumulative 53,219 shares sold over the past year, adds an extra layer of scrutiny to Vistra’s otherwise analyst-endorsed...

In early March 2026, Roku reported Q4 2025 results that surpassed analyst expectations and paired them with optimistic guidance for 2026, alongside multiple upgrades from Wall Street. A flurry of platform moves, from adding Apple TV to The Roku Channel to securing exclusive X Games League streaming and enhancing live and local TV features, points to Roku sharpening both user engagement and monetization across its ecosystem. Now, we’ll examine how Roku’s better‑than‑expected earnings and...

In recent weeks, Unity Software has attracted renewed attention as multiple research firms reiterated or upgraded positive ratings and raised earnings forecasts, while options activity and analyst commentary underscored expectations for improving margins despite softer revenue growth and sector-wide concern about AI’s impact on software providers. At the same time, investors are weighing upbeat analyst sentiment and stronger earnings estimates against insider share sales and worries that AI...

Cytokinetics (NasdaqGS:CYTK) presented new clinical data on MYQORZO (aficamten) for obstructive hypertrophic cardiomyopathy at a major cardiology conference. The updates covered exercise capacity outcomes, effectiveness across patients with and without hypertension, and safety during treatment interruption and restart. The new analyses expand the clinical profile of MYQORZO, a recently approved oHCM therapy, and add detail on how the drug performs in real treatment scenarios. Cytokinetics...

Wondering whether ServisFirst Bancshares is attractively priced at its current level? This article focuses squarely on what the recent share performance might be telling you about value. The stock last closed at US$73.73, with returns of 2.7% year to date, a 14.4% decline over the past month, and a 9.7% decline over the past year, while still showing a 35.2% gain over three years and 31.1% over five years. These mixed returns have kept ServisFirst Bancshares on the radar for investors who...

Wondering whether DocuSign at around US$46.82 still lines up with what you would consider a fair price? This article walks through the key valuation checks so you can put the current share price in context. The stock has seen a mixed run recently, with a 3.8% decline over the last 7 days, a 4.5% gain over the last 30 days, and year to date and 1 year returns of 27.8% and 43.9% declines respectively. Recent headlines have continued to focus on DocuSign's role in digital agreement workflows...

Halozyme Therapeutics has appointed David Ramsay as interim Chief Financial Officer, effective March 23, 2026, tasking him with overseeing all financial operations while the company continues its search for a permanent CFO. Ramsay’s return, after previously guiding Halozyme from a private business to a billion-dollar public biopharmaceutical company, offers investors continuity in financial leadership during a key transition period. We’ll now examine how Ramsay’s return as interim CFO may...

Earlier this month, PrintKK announced its integration with Etsy, allowing marketplace sellers to design and sell over 1,000 customizable products globally while PrintKK manages production, packaging, and shipping through its fulfillment network. Around the same time, Etsy overhauled its shop review system to use lifetime reviews with recency weighting and completed the sale of Depop, moves that sharpen focus on marketplace quality and core operations. Next, we’ll examine how Etsy’s shift to...

Gold.com (NYSE:GOLD) has appointed Juan Sartori to its Board of Directors with immediate effect. The move coincides with the retirement of longtime director Beverley Lepine after more than a decade of service. Sartori brings experience in digital finance, commodities, and global capital markets to the company’s board. Gold.com, trading at $46.72, has seen a 34.4% return year to date and a 72.0% return over the past year, with longer term 3 year and 5 year returns of 74.1% and 183.2%...

LyondellBasell recently announced that David Dennison, a nearly 30‑year industry veteran who joined the company in 2007 and most recently served as a vice president in its Circular and Low Carbon Solutions business, will become head of investor relations in May 2026, succeeding retiring long‑time executive Dave Kinney. Dennison’s background in planning, commercial leadership and circular solutions could meaningfully shape how LyondellBasell communicates its transition toward recycling,...

In early March 2026, AvePoint announced the past general availability of its AgentPulse Command Center, expanding multicloud observability and governance for autonomous AI agents across Microsoft 365 and Google Cloud, with unified monitoring, lifecycle management, and cost controls to reduce shadow AI, data exposure, and surprise usage bills. A distinctive feature is the single-pane view across Copilot Studio, Microsoft Foundry, SharePoint agents, and Vertex AI, giving enterprises...

Live Nation Entertainment has settled the US Department of Justice’s antitrust lawsuit without admitting wrongdoing, extending its consent decree by eight years and setting up a US$280 million fund to address state damages claims. The agreement lets Live Nation retain Ticketmaster under stricter operating conditions while leaked internal messages and ongoing state actions keep its ticketing practices under intense scrutiny. We’ll now examine how the extended DOJ consent decree and continuing...

In early March 2026, Incyte reported a U.S. FDA Complete Response Letter for an additional lung cancer indication of Zynyz due to compliance issues at a third‑party fill‑finish facility, while also securing European Commission approval for Zynyz in combination with chemotherapy as a first‑line treatment for advanced anal cancer. The contrast between a regulatory setback tied to a partner’s manufacturing site in the U.S. and a fresh approval expanding Zynyz’s reach in Europe underscores how...

Frontdoor (FTDR) is back in focus after reporting Q4 revenue of $433 million, a 13.1% year over year increase, along with earnings that exceeded expectations and full year revenue guidance slightly below projections. See our latest analysis for Frontdoor. Since the earnings release, Frontdoor’s share price has moved to US$64.22, with a 13.38% 1 month share price return and a 69.58% 1 year total shareholder return, which may suggest building momentum despite some recent short term pullback. If...

In March 2026, Oklo Inc. and Centrus Energy agreed to pursue a joint venture for high-assay low-enriched uranium deconversion at Centrus’ Piketon, Ohio site, while Centrus also reported lower-than-expected quarterly earnings affected by a delayed Russian shipment and outlined increased capital spending plans. Centrus’ recent collaboration with Palantir on AI-driven enrichment optimization and its talks with Oklo on an integrated HALEU hub highlight how technology and fuel-cycle partnerships...

Wondering if United Bankshares at around US$39.38 is still a fair deal or starting to look stretched? This article breaks down what the current share price might be implying about value. The stock’s returns range from a 1.4% decline over the last 7 days and a 10.7% decline over the last 30 days, to gains of 2.6% year to date, 17.5% over 1 year, 25.7% over 3 years and 25.2% over 5 years. These figures can mean very different things depending on how you think about risk and timing. Recent...